<ADSBIBCODE>2012PLoSO...748146Y</ADSBIBCODE>
<citation_list doi="10.1371/journal.pone.0048146" file="doi/10.1371/./jo/ur/na/l,/po/ne/,0/04/81/46//metadata.xml" bibcode="2012PLoSO...748146Y">
  <citation key="ref1">
    <journal_title>Proc Natl Acad Sci U S A</journal_title>
    <author>SB Prusiner</author>
    <volume>95</volume>
    <first_page>13363</first_page>
    <cYear>1998</cYear>
    <doi provider="crossref">10.1073/pnas.95.23.13363</doi>
    <article_title>Prions</article_title>
  </citation>
  <citation key="ref2">
    <journal_title>Annu Rev Pathol</journal_title>
    <author>A Aguzzi</author>
    <volume>3</volume>
    <first_page>11</first_page>
    <cYear>2008</cYear>
    <doi provider="crossref">10.1146/annurev.pathmechdis.3.121806.154326</doi>
    <article_title>Molecular mechanisms of prion pathogenesis</article_title>
  </citation>
  <citation key="ref3">
    <journal_title>Trends Biochem Sci</journal_title>
    <author>C Soto</author>
    <volume>36</volume>
    <first_page>151</first_page>
    <cYear>2011</cYear>
    <doi provider="crossref">10.1016/j.tibs.2010.11.001</doi>
    <article_title>Prion hypothesis: the end of the controversy?</article_title>
  </citation>
  <citation key="ref4">
    <journal_title>PLoS Pathog</journal_title>
    <author>J Ma</author>
    <volume>8</volume>
    <first_page>e1002589</first_page>
    <cYear>2012</cYear>
    <doi provider="crossref">10.1371/journal.ppat.1002589</doi>
    <article_title>The role of cofactors in prion propagation and infectivity</article_title>
  </citation>
  <citation key="ref5">
    <journal_title>Annu Rev Neurosci</journal_title>
    <author>A Aguzzi</author>
    <volume>31</volume>
    <first_page>439</first_page>
    <cYear>2008</cYear>
    <doi provider="crossref">10.1146/annurev.neuro.31.060407.125620</doi>
    <article_title>The prion&amp;apos;s elusive reason for being</article_title>
  </citation>
  <citation key="ref6">
    <journal_title>J Mol Med (Berl)</journal_title>
    <author>X Roucou</author>
    <volume>83</volume>
    <first_page>3</first_page>
    <cYear>2005</cYear>
    <doi provider="crossref">10.1007/s00109-004-0605-5</doi>
    <article_title>Cellular prion protein neuroprotective function: implications in prion diseases</article_title>
  </citation>
  <citation key="ref7">
    <journal_title>Antioxid Redox Signal</journal_title>
    <author>N Singh</author>
    <volume>12</volume>
    <first_page>1271</first_page>
    <cYear>2010</cYear>
    <doi provider="crossref">10.1089/ars.2009.2628</doi>
    <article_title>Redox control of prion and disease pathogenesis</article_title>
  </citation>
  <citation key="ref8">
    <journal_title>FASEB J</journal_title>
    <author>Y Pan</author>
    <volume>20</volume>
    <first_page>1886</first_page>
    <cYear>2006</cYear>
    <doi provider="crossref">10.1096/fj.06-6138fje</doi>
    <article_title>Cellular prion protein promotes invasion and metastasis of gastric cancer</article_title>
  </citation>
  <citation key="ref9">
    <journal_title>FASEB J</journal_title>
    <author>J Liang</author>
    <volume>21</volume>
    <first_page>2247</first_page>
    <cYear>2007</cYear>
    <doi provider="crossref">10.1096/fj.06-7799com</doi>
    <article_title>Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS</article_title>
  </citation>
  <citation key="ref10">
    <journal_title>J Orthop Res</journal_title>
    <author>V Sollazzo</author>
    <volume>30</volume>
    <first_page>1004</first_page>
    <cYear>2012</cYear>
    <doi provider="crossref">10.1002/jor.22034</doi>
    <article_title>Prion proteins (PRNP and PRND) are over-expressed in osteosarcoma</article_title>
  </citation>
  <citation key="ref11">
    <journal_title>Ann Oncol</journal_title>
    <author>F Meslin</author>
    <volume>18</volume>
    <first_page>1793</first_page>
    <cYear>2007</cYear>
    <doi provider="crossref">10.1093/annonc/mdm406</doi>
    <article_title>Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer</article_title>
  </citation>
  <citation key="ref12">
    <journal_title>J Biol Chem</journal_title>
    <author>C Li</author>
    <volume>285</volume>
    <first_page>30328</first_page>
    <cYear>2010</cYear>
    <doi provider="crossref">10.1074/jbc.M110.147413</doi>
    <article_title>Pro-prion binds filamin A, facilitating its interaction with integrin beta1, and contributes to melanomagenesis</article_title>
  </citation>
  <citation key="ref13">
    <journal_title>J Clin Invest</journal_title>
    <author>C Li</author>
    <volume>119</volume>
    <first_page>2725</first_page>
    <cYear>2009</cYear>
    <doi provider="crossref">10.1172/JCI39542</doi>
    <article_title>Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer</article_title>
  </citation>
  <citation key="ref14">
    <journal_title>Cancer Lett</journal_title>
    <author>M Mehrpour</author>
    <volume>290</volume>
    <first_page>1</first_page>
    <cYear>2010</cYear>
    <doi provider="crossref">10.1016/j.canlet.2009.07.009</doi>
    <article_title>Prion protein: From physiology to cancer biology</article_title>
  </citation>
  <citation key="ref15">
    <journal_title>Cell Mol Life Sci</journal_title>
    <author>QQ Li</author>
    <volume>66</volume>
    <first_page>504</first_page>
    <cYear>2009</cYear>
    <doi provider="crossref">10.1007/s00018-008-8548-6</doi>
    <article_title>The role of P-glycoprotein/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel</article_title>
  </citation>
  <citation key="ref16">
    <journal_title>Cancer Res</journal_title>
    <author>M Diarra-Mehrpour</author>
    <volume>64</volume>
    <first_page>719</first_page>
    <cYear>2004</cYear>
    <doi provider="crossref">10.1158/0008-5472.CAN-03-1735</doi>
    <article_title>Prion protein prevents human breast carcinoma cell line from tumor necrosis factor alpha-induced cell death</article_title>
  </citation>
  <citation key="ref17">
    <journal_title>Cancer Res</journal_title>
    <author>F Meslin</author>
    <volume>67</volume>
    <first_page>10910</first_page>
    <cYear>2007</cYear>
    <doi provider="crossref">10.1158/0008-5472.CAN-07-0512</doi>
    <article_title>Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death</article_title>
  </citation>
  <citation key="ref18">
    <journal_title>Cell Death Differ</journal_title>
    <author>X Roucou</author>
    <volume>12</volume>
    <first_page>783</first_page>
    <cYear>2005</cYear>
    <doi provider="crossref">10.1038/sj.cdd.4401629</doi>
    <article_title>Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells</article_title>
  </citation>
  <citation key="ref19">
    <journal_title>Neurochem Res</journal_title>
    <author>N Wang</author>
    <volume>36</volume>
    <first_page>2169</first_page>
    <cYear>2011</cYear>
    <doi provider="crossref">10.1007/s11064-011-0541-z</doi>
    <article_title>Quinoprotein adducts accumulate in the substantia nigra of aged rats and correlate with dopamine-induced toxicity in SH-SY5Y cells</article_title>
  </citation>
  <citation key="ref20">
    <journal_title>Nature</journal_title>
    <author>C Kuwahara</author>
    <volume>400</volume>
    <first_page>225</first_page>
    <cYear>1999</cYear>
    <doi provider="crossref">10.1038/22241</doi>
    <article_title>Prions prevent neuronal cell-line death</article_title>
  </citation>
  <citation key="ref21">
    <journal_title>Brain Res Mol Brain Res</journal_title>
    <author>BH Kim</author>
    <volume>124</volume>
    <first_page>40</first_page>
    <cYear>2004</cYear>
    <doi provider="crossref">10.1016/j.molbrainres.2004.02.005</doi>
    <article_title>The cellular prion protein (PrPC) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation</article_title>
  </citation>
  <citation key="ref22">
    <journal_title>Mol Neurobiol</journal_title>
    <author>WC Shyu</author>
    <volume>26</volume>
    <first_page>1</first_page>
    <cYear>2002</cYear>
    <doi provider="crossref">10.1385/MN:26:1:001</doi>
    <article_title>Molecular modulation of expression of prion protein by heat shock</article_title>
  </citation>
  <citation key="ref23">
    <journal_title>Neuropathol Appl Neurobiol</journal_title>
    <author>WM Williams</author>
    <volume>30</volume>
    <first_page>161</first_page>
    <cYear>2004</cYear>
    <doi provider="crossref">10.1111/j.1365-2990.2003.00523.x</doi>
    <article_title>Ageing and exposure to oxidative stress in vivo differentially affect cellular levels of PrP in mouse cerebral microvessels and brain parenchyma</article_title>
  </citation>
  <citation key="ref24">
    <journal_title>J Neurosci Res</journal_title>
    <author>WC Shyu</author>
    <volume>80</volume>
    <first_page>887</first_page>
    <cYear>2005</cYear>
    <doi provider="crossref">10.1002/jnr.20509</doi>
    <article_title>Hypoglycemia enhances the expression of prion protein and heat-shock protein 70 in a mouse neuroblastoma cell line</article_title>
  </citation>
  <citation key="ref25">
    <journal_title>Oncogene</journal_title>
    <author>K Podar</author>
    <volume>27</volume>
    <first_page>721</first_page>
    <cYear>2008</cYear>
    <doi provider="crossref">10.1038/sj.onc.1210679</doi>
    <article_title>A pivotal role for Mcl-1 in Bortezomib-induced apoptosis</article_title>
  </citation>
  <citation key="ref26">
    <journal_title>Toxicol Lett</journal_title>
    <author>M Tampio</author>
    <volume>188</volume>
    <first_page>214</first_page>
    <cYear>2009</cYear>
    <doi provider="crossref">10.1016/j.toxlet.2009.04.016</doi>
    <article_title>Induction of PUMA-alpha and down-regulation of PUMA-beta expression is associated with benzo(a)pyrene-induced apoptosis in MCF-7 cells</article_title>
  </citation>
  <citation key="ref27">
    <journal_title>J Neurochem</journal_title>
    <author>E Sanz</author>
    <volume>105</volume>
    <first_page>2404</first_page>
    <cYear>2008</cYear>
    <doi provider="crossref">10.1111/j.1471-4159.2008.05326.x</doi>
    <article_title>Anti-apoptotic effect of Mao-B inhibitor PF9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] is mediated by p53 pathway inhibition in MPP+-treated SH-SY5Y human dopaminergic cells</article_title>
  </citation>
  <citation key="ref28">
    <journal_title>Am J Physiol Heart Circ Physiol</journal_title>
    <author>J Liu</author>
    <volume>295</volume>
    <first_page>H1956</first_page>
    <cYear>2008</cYear>
    <doi provider="crossref">10.1152/ajpheart.00407.2008</doi>
    <article_title>ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes</article_title>
  </citation>
  <citation key="ref29">
    <journal_title>J Biol Chem</journal_title>
    <author>E Paitel</author>
    <volume>278</volume>
    <first_page>10061</first_page>
    <cYear>2003</cYear>
    <doi provider="crossref">10.1074/jbc.M211580200</doi>
    <article_title>Cellular prion protein sensitizes neurons to apoptotic stimuli through Mdm2-regulated and p53-dependent caspase 3-like activation</article_title>
  </citation>
  <citation key="ref30">
    <journal_title>J Biol Chem</journal_title>
    <author>E Paitel</author>
    <volume>279</volume>
    <first_page>612</first_page>
    <cYear>2004</cYear>
    <doi provider="crossref">10.1074/jbc.M310453200</doi>
    <article_title>Primary cultured neurons devoid of cellular prion display lower responsiveness to staurosporine through the control of p53 at both transcriptional and post-transcriptional levels</article_title>
  </citation>
  <citation key="ref31">
    <journal_title>Endocr Relat Cancer</journal_title>
    <author>M Lacroix</author>
    <volume>13</volume>
    <first_page>293</first_page>
    <cYear>2006</cYear>
    <doi provider="crossref">10.1677/erc.1.01172</doi>
    <article_title>p53 and breast cancer, an update</article_title>
  </citation>
  <citation key="ref32">
    <journal_title>FEBS J</journal_title>
    <author>S Cagnol</author>
    <volume>277</volume>
    <first_page>2</first_page>
    <cYear>2010</cYear>
    <doi provider="crossref">10.1111/j.1742-4658.2009.07366.x</doi>
    <article_title>ERK and cell death: mechanisms of ERK-induced cell death--apoptosis, autophagy and senescence</article_title>
  </citation>
  <citation key="ref33">
    <journal_title>Cell Death Differ</journal_title>
    <author>K Balmanno</author>
    <volume>16</volume>
    <first_page>368</first_page>
    <cYear>2009</cYear>
    <doi provider="crossref">10.1038/cdd.2008.148</doi>
    <article_title>Tumour cell survival signalling by the ERK1/2 pathway</article_title>
  </citation>
  <citation key="ref34">
    <journal_title>Prostate</journal_title>
    <author>R Thomas</author>
    <volume>68</volume>
    <first_page>1405</first_page>
    <cYear>2008</cYear>
    <doi provider="crossref">10.1002/pros.20808</doi>
    <article_title>HIF-1 alpha: a key survival factor for serum-deprived prostate cancer cells</article_title>
  </citation>
  <citation key="ref35">
    <journal_title>Proc Natl Acad Sci U S A</journal_title>
    <author>K Lee</author>
    <volume>106</volume>
    <first_page>2353</first_page>
    <cYear>2009</cYear>
    <doi provider="crossref">10.1073/pnas.0812801106</doi>
    <article_title>Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells</article_title>
  </citation>
  <citation key="ref36">
    <journal_title>Free Radic Biol Med</journal_title>
    <author>V Anantharam</author>
    <volume>45</volume>
    <first_page>1530</first_page>
    <cYear>2008</cYear>
    <doi provider="crossref">10.1016/j.freeradbiomed.2008.08.028</doi>
    <article_title>Opposing roles of prion protein in oxidative stress- and ER stress-induced apoptotic signaling</article_title>
  </citation>
</citation_list>